Back to discover
Drug
Palmitic Acid
Research stageEmerging researchRising momentum
Also known as 1-Pentadecanecarboxylic acid, 1-hexyldecanoic acid, Aliphatic carboxylic acid, C16:0, Hexadecanoic acid+6 more
1-Pentadecanecarboxylic acid, 1-hexyldecanoic acid, Aliphatic carboxylic acid, C16:0, Hexadecanoic acid, Hexadecoic acid, Hexadecylic acid, Hexaectylic acid, Palmitinsäure, n-Hexadecanoic acid, Palmitinic acid.
3
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2025-01-18International journal of molecular sciences
Thyroid hormone increases fatty acid use in fetal ovine cardiac myocytes.
Research2023-11-01Physiological reports
Research2019-07-30Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Palmitic Acid
Aliases & brands
1-Pentadecanecarboxylic acid1-hexyldecanoic acidAliphatic carboxylic acid, C16:0Hexadecanoic acidHexadecoic acidHexadecylic acidHexaectylic acidPalmitinsäuren-Hexadecanoic acidPalmitinic acid
RxNorm CUI
1426390
ChEMBL ID
CHEMBL82293
UNII
2V16EO95H1
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Publications over time
20192025
Most influential
Major research themes4
Fatty Acids1Metabolic Syndrome1Myocytes, Cardiac1Palmitic Acid1
Journals, researchers & institutions
Top journals
- Inflammation research : official journal of the European Histamine Research Society ... [et al.]1
- International journal of molecular sciences1
- Physiological reports1
Leading researchers
- Bajdak-Rusinek K1
- Ceja-Galicia ZA1
- Cespedes-Acuña CLA1
- Chattergoon N1
- El-Hafidi M1
- Jonker SS1
- Korbecki J1
- Louey S1
Leading institutions
free-text, unnormalised
- Center for Developmental Health1
- Instituto Nacional de Cardiología Ignacio Chávez1
- School of Medicine in Katowice1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Active research areas
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature